Our study has uncovered an important role of Kindlin-2 in liver fibrosis progression and suggests that inhibition of Kindlin-2 may represent a novel therapeutic approach for the treatment of hepatic fibrosis. The gene discussed is FERMT2; the disease is Hepatic fibrosis.